These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 8059232

  • 41. Clinical consequences of antiphospholipid antibodies.
    Derksen RH, de Groot PG.
    Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Anticardiolipin antibodies in acquired immunodeficiency syndrome.
    Stimmler MM, Quismorio FP, McGehee WG, Boylen T, Sharma OP.
    Arch Intern Med; 1989 Aug; 149(8):1833-5. PubMed ID: 2504122
    [Abstract] [Full Text] [Related]

  • 44. Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome.
    Sipek-Dolnicar A, Hojnik M, Rozman B, Vizjak A, Ferluga D.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):707-10. PubMed ID: 11020961
    [Abstract] [Full Text] [Related]

  • 45. IgA antiphospholipid antibodies are an independent risk factor for thromboses.
    Shen YM, Lee R, Frenkel E, Sarode R.
    Lupus; 2008 Nov 25; 17(11):996-1003. PubMed ID: 18852223
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Antiphospholipid sydrome--recurrent thrombosis and foetal loss due to antiphospholipid antibodies].
    Elezović I, Matijević-Aleksić N, Rolović Z.
    Srp Arh Celok Lek; 1994 Nov 25; 122(5-6):179-81. PubMed ID: 17977423
    [Abstract] [Full Text] [Related]

  • 49. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
    Asherson RA, Cervera R, Merrill JT, Erkan D.
    Semin Thromb Hemost; 2008 Apr 25; 34(3):256-66. PubMed ID: 18720305
    [Abstract] [Full Text] [Related]

  • 50. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
    Musiał J, Swadźba J, Jankowski M, Grzywacz M, Bazan-Socha S, Szczeklik A.
    Thromb Haemost; 1997 Oct 25; 78(4):1173-7. PubMed ID: 9364980
    [Abstract] [Full Text] [Related]

  • 51. The lupus anticoagulant and antiphospholipid antibodies.
    Pertusi RM.
    J Am Osteopath Assoc; 1992 Aug 25; 92(8):1021-5. PubMed ID: 1429061
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW, Rangarajan S, Savidge GF.
    Clin Appl Thromb Hemost; 2008 Jul 25; 14(3):332-7. PubMed ID: 17895508
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug 25; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.